DE69322286D1 - Verabreichungsvorrichtungen mit gestützten flüssigen membranen - Google Patents

Verabreichungsvorrichtungen mit gestützten flüssigen membranen

Info

Publication number
DE69322286D1
DE69322286D1 DE69322286T DE69322286T DE69322286D1 DE 69322286 D1 DE69322286 D1 DE 69322286D1 DE 69322286 T DE69322286 T DE 69322286T DE 69322286 T DE69322286 T DE 69322286T DE 69322286 D1 DE69322286 D1 DE 69322286D1
Authority
DE
Germany
Prior art keywords
beneficial agent
aqueous environment
supported liquid
hydrophobic
administration devices
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69322286T
Other languages
English (en)
Other versions
DE69322286T2 (de
Inventor
Scott M Herbig
Kelly L Smith
Eikeren Paul Van
James B West
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE69322286D1 publication Critical patent/DE69322286D1/de
Publication of DE69322286T2 publication Critical patent/DE69322286T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/009—Sachets, pouches characterised by the material or function of the envelope
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • External Artificial Organs (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Laminated Bodies (AREA)
DE69322286T 1992-11-30 1993-08-12 Verabreichungsvorrichtungen mit gestützten flüssigen membranen Expired - Fee Related DE69322286T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98281592A 1992-11-30 1992-11-30
PCT/US1993/007463 WO1994012159A1 (en) 1992-11-30 1993-08-12 Supported liquid membrane delivery devices

Publications (2)

Publication Number Publication Date
DE69322286D1 true DE69322286D1 (de) 1999-01-07
DE69322286T2 DE69322286T2 (de) 1999-04-22

Family

ID=25529534

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69322286T Expired - Fee Related DE69322286T2 (de) 1992-11-30 1993-08-12 Verabreichungsvorrichtungen mit gestützten flüssigen membranen

Country Status (10)

Country Link
US (1) US5603953A (de)
EP (1) EP0670717B1 (de)
JP (1) JP2847326B2 (de)
AT (1) ATE173616T1 (de)
CA (1) CA2150019C (de)
DE (1) DE69322286T2 (de)
DK (1) DK0670717T3 (de)
ES (1) ES2123665T3 (de)
FI (1) FI112600B (de)
WO (1) WO1994012159A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465188B1 (en) 1990-06-11 2002-10-15 Gilead Sciences, Inc. Nucleic acid ligand complexes
US5985164A (en) * 1994-03-07 1999-11-16 Regents Of The University Of California Method for forming a filter
US5798042A (en) * 1994-03-07 1998-08-25 Regents Of The University Of California Microfabricated filter with specially constructed channel walls, and containment well and capsule constructed with such filters
US5893974A (en) * 1994-03-07 1999-04-13 Regents Of University Of California Microfabricated capsules for immunological isolation of cell transplants
US5985328A (en) * 1994-03-07 1999-11-16 Regents Of The University Of California Micromachined porous membranes with bulk support
US5770076A (en) * 1994-03-07 1998-06-23 The Regents Of The University Of California Micromachined capsules having porous membranes and bulk supports
CN1096862C (zh) 1994-05-06 2002-12-25 辉瑞大药厂 阿齐霉素的控释剂型
US8071737B2 (en) * 1995-05-04 2011-12-06 Glead Sciences, Inc. Nucleic acid ligand complexes
GB9509764D0 (en) * 1995-05-15 1995-07-05 Tillotts Pharma Ag Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
GB9609094D0 (en) * 1996-05-01 1996-07-03 Univ Strathclyde Delivery device
US6086769A (en) * 1996-09-16 2000-07-11 Commodore Separation Technologies, Inc. Supported liquid membrane separation
US5938923A (en) * 1997-04-15 1999-08-17 The Regents Of The University Of California Microfabricated filter and capsule using a substrate sandwich
US6248391B1 (en) * 1997-07-16 2001-06-19 Bpsi Holdings, Inc. Bright white film coatings and film coating compositions therefor
ES2205595T3 (es) * 1997-12-31 2004-05-01 Alza Corporation Sistema de control osmotico de administracion de medicamento.
IL137982A0 (en) * 1998-03-19 2001-10-31 Merck & Co Inc Liquid polymeric compositions of controlled release of bioactive substances
FR2790404B1 (fr) * 1999-03-01 2001-11-02 Virbac Sa Compositions pour le domaine aquatique contenant au moins une molecule active contenue dans au moins un vecteur microparticulaire ou nanoparticulaire, et son utilisation
GB9920170D0 (en) * 1999-08-25 1999-10-27 Univ Portsmouth A passive sampling device
US6521188B1 (en) * 2000-11-22 2003-02-18 Industrial Technology Research Institute Microfluidic actuator
EP1388005B1 (de) * 2001-04-26 2006-11-15 Varian, Inc. Hohlfasermembran probenpräparationsanordnungen
AP1899A (en) * 2003-08-08 2008-10-10 Biovail Lab Int Srl Modified-release tablet of bupropion hydrochloride
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
US7445939B2 (en) * 2004-02-27 2008-11-04 Varian, Inc. Stable liquid membranes for liquid phase microextraction
US20070181054A1 (en) * 2006-02-03 2007-08-09 Adair Joel E Heated volatile dispensing device with use-up indicator
JP4327841B2 (ja) * 2006-12-20 2009-09-09 日東電工株式会社 経皮吸収製剤の製造装置および製造方法
US20090095164A1 (en) * 2007-05-17 2009-04-16 Salvatore Albert Celeste Method of enhancing beverages by means of a unique microencapsulated delivery system
US11039707B2 (en) * 2007-05-17 2021-06-22 International Flavors & Fragrances Inc. Microencapsulated delivery system
CA3008794C (en) 2012-03-29 2021-03-16 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
CA2904389C (en) 2013-03-14 2018-09-18 Jerome J. Schentag Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
US11213791B2 (en) * 2015-10-23 2022-01-04 Hewlett-Packard Development Company, L.P. Nano wire microporous structure
WO2018200808A1 (en) 2017-04-26 2018-11-01 The Penn State Research Foundation Free-standing liquid membranes for substance separation, filtration, extraction, and blockage

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965255A (en) * 1974-05-01 1976-06-22 E. E. Eljim Ecology Ltd. Controlled drug releasing preparations
US3952741A (en) * 1975-01-09 1976-04-27 Bend Research Inc. Controlled release delivery system by an osmotic bursting mechanism
US4016880A (en) * 1976-03-04 1977-04-12 Alza Corporation Osmotically driven active agent dispenser
US4201691A (en) * 1978-01-16 1980-05-06 Exxon Research & Engineering Co. Liquid membrane generator
US4183960A (en) * 1978-02-01 1980-01-15 Exxon Research & Engineering Co. Detoxification by means of the controlled, in vivo secretion triggered rupture of liquid membrane capsules
DE3571924D1 (en) * 1984-04-11 1989-09-07 Thiemann Arzneimittel Gmbh Dosage units for controlled release of active material
US4657543A (en) * 1984-07-23 1987-04-14 Massachusetts Institute Of Technology Ultrasonically modulated polymeric devices for delivering compositions
DE3486409T2 (de) * 1984-08-17 1996-04-25 Wellcome Found Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs.
JPH0739457B2 (ja) * 1986-05-14 1995-05-01 タキロン株式会社 両親媒性セグメントポリウレタン
FR2599270B3 (fr) * 1986-06-03 1988-12-30 Pharmacie Galenique Lab Procede de preparation d'une membrane destinee a tester la diffusion passive des medicaments.
US5034317A (en) * 1987-01-30 1991-07-23 Polaroid Corporation Enzyme controlled release system and organic conjugate reactant
US5057320A (en) * 1988-08-01 1991-10-15 Nutrition 21 Means and method for increasing skin respiration
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
US5026342A (en) * 1988-10-26 1991-06-25 Biopore, Inc. Noningestible separation barrier with plugged pores
DK0542926T3 (da) * 1990-08-07 1995-05-15 Pfizer Brug af grænsefladepolymeriserede membraner i frigivelsesanordninger
ES2053339T3 (es) * 1990-09-28 1994-07-16 Pfizer Dispositivo dispensador conteniendo un medio hidrofobo.
DE9015551U1 (de) * 1990-11-14 1992-03-12 Röhm GmbH, 6100 Darmstadt Orale Arzneiform und Überzugsmittel, enthaltend ein im Colon abbaubares Polysaccarid

Also Published As

Publication number Publication date
EP0670717B1 (de) 1998-11-25
FI112600B (fi) 2003-12-31
JPH07509254A (ja) 1995-10-12
FI935299A (fi) 1994-05-31
WO1994012159A1 (en) 1994-06-09
FI935299A0 (fi) 1993-11-29
ATE173616T1 (de) 1998-12-15
DK0670717T3 (da) 1999-08-09
JP2847326B2 (ja) 1999-01-20
DE69322286T2 (de) 1999-04-22
US5603953A (en) 1997-02-18
CA2150019A1 (en) 1994-06-09
EP0670717A1 (de) 1995-09-13
CA2150019C (en) 1999-01-05
ES2123665T3 (es) 1999-01-16

Similar Documents

Publication Publication Date Title
DE69322286D1 (de) Verabreichungsvorrichtungen mit gestützten flüssigen membranen
PT99066A (pt) Dispositivo de administracao que compreende um meio hidrofobico
ES2041006T3 (es) La utilizacion de membranas asimetricas en dispositivos de suministro.
WO1996041621A3 (en) Osmotic-delivery devices having vapor-permeable coatings
ATE126445T1 (de) Klebende vorrichtung zur transdermalen verabreichung eines wirkstoffs.
ES2052071T3 (es) Cuerpo oclusivo para administrar una sustancia fisiologicamente activa.
DK0523172T3 (da) Osmotisk doseringssystem til afgivelse af flydende lægemiddel
DK156289D0 (da) Farmaceutisk praeparat indrettet til kontrolleret afgivelse af aktiv bestanddel
DE60036534D1 (de) Feste pharmazeutische formulierungen auf basis von sulfoalkylethern des cyclodextrins zur verzögerten freisetzung
FI940866A0 (fi) pH-herkällä laukaisimella varustetut, osmoottiset, hajoavat laitteet aineen vapauttamiseksi
YU47271B (sh) Presa za tabletiranje uredjaj za uklanjanje obloge i preparat za kontrolisano oslobadjanje jedne ili više aktivnih supstanci
DE69425828D1 (de) Osmotische vorrichtung mit dampfdurchlaessiger beschichtung
IE882898L (en) Solubility modulated drug delivery device
SE7903973L (sv) Doseringssystem
ATE200506T1 (de) Wässrige phenolharzdispersionen
AR000076A1 (es) Formulación de polvo humectable, dispersion acuosade dicha formulación de polvo humectable, proce so para preparar dicha formulacion, metodo para administar dicha dispersion acuosa y metodo para el tratamiento de post-emergencia de malezas objetivoen un cultivo con dicha dispersion acuosa.
JPS56139424A (en) Adhesive agent
JPH01223137A (ja) 液状活性物質含有膜

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee